MANCINI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 97
AS - Asia 66
EU - Europa 60
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 5
SA - Sud America 5
Totale 240
Nazione #
US - Stati Uniti d'America 93
SG - Singapore 33
IT - Italia 20
NL - Olanda 14
CN - Cina 12
RU - Federazione Russa 7
VN - Vietnam 7
HK - Hong Kong 5
FR - Francia 4
BR - Brasile 3
FI - Finlandia 3
JP - Giappone 3
KR - Corea 3
CA - Canada 2
CR - Costa Rica 2
GB - Regno Unito 2
IN - India 2
PT - Portogallo 2
SC - Seychelles 2
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DE - Germania 1
EC - Ecuador 1
IQ - Iraq 1
KE - Kenya 1
MA - Marocco 1
MD - Moldavia 1
NE - Niger 1
PL - Polonia 1
SE - Svezia 1
UA - Ucraina 1
VE - Venezuela 1
Totale 233
Città #
Singapore 23
Amsterdam 14
San Jose 14
Ashburn 9
Council Bluffs 9
Dallas 5
Hong Kong 5
Moscow 5
New York 5
Lauterbourg 4
Santa Clara 4
Verona 4
Denver 3
New Orleans 3
Seoul 3
Tokyo 3
Boardman 2
Brasília 2
Chengdu 2
Chicago 2
Detroit 2
Helsinki 2
Los Angeles 2
Perugia 2
Phoenix 2
Piscataway 2
San José 2
Toronto 2
Turin 2
Agadir 1
Beijing 1
Birmingham 1
Bristol 1
Brooklyn 1
Buon Ma Thuot 1
Bắc Giang 1
Bắc Ninh 1
Caracas 1
Chennai 1
Chisinau 1
Duque de Caxias 1
Foligno 1
Godley 1
Guayaquil 1
Haiphong 1
Hanoi 1
Hefei 1
Joliet 1
Kyiv 1
Lisbon 1
London 1
L’Aquila 1
Manassas 1
Milan 1
Nairobi 1
Niamey 1
North Kansas City 1
Nuremberg 1
Olomouc 1
Pazardzhik 1
Qingdao 1
Queens 1
Rome 1
Salt Lake City 1
Seattle 1
Stockholm 1
Temryuk 1
Wellington 1
Wroclaw 1
Wuhan 1
Totale 180
Nome #
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia 98
Targetable Mutations in BRAF V600E–Negative Hairy-Cell Leukemia 49
Classic Hairy Cell Leukemia With MAP2K1 Mutation: Diagnosis and Targeted Therapy 37
Real‐life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy‐cell leukemia: A multicenter Italian retrospective study (HCL‐PG03R) 30
Short BRAF+MEK coinhibition, alone and combined with anti‐CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator‐sponsored multi‐center phase 2 clinical trial 16
An old but still good friend: chemoimmunotherapy in HCL 10
Totale 240
Categoria #
all - tutte 1.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20234 0 0 0 0 0 0 0 0 0 2 2 0
2023/202418 0 2 0 0 0 4 2 0 4 2 2 2
2024/202516 0 3 0 4 1 1 1 1 4 0 1 0
2025/2026137 3 3 4 7 38 17 19 5 17 19 4 1
2026/202765 9 12 14 30 0 0 0 0 0 0 0 0
Totale 240